Real-world outcomes of cabotegravir and rilpivirine for treating PLHIV in Spain: a multicentre, ambispective and nationwide study (the RELATIVITY cohort)

被引：0

作者：

Buzon Martin, Luis ^{[1
]}

Luisa Montes, Maria ^{[2
]}

Galindo Puerto, Maria J. ^{[3
]}

Torralba Gonzalez, Miguel ^{[4
]}

Pousada, Guillermo ^{[5
]}

Santacreu, Mireia ^{[6
]}

de los Santos, Ignacio ^{[7
]}

Cabello Ubeda, Alfonso ^{[8
]}

Cabello Clotet, Noemi ^{[9
]}

Crusells-Canales, Maria Jose ^{[10
]}

Enrique Morano, Luis ^{[5
]}

Martin Rico, Patricia ^{[11
]}

Montero Hernandez, Carmen ^{[12
]}

Diaz de Santiago, Alberto ^{[13
]}

Cecilio, Alvaro ^{[14
]}

de Zarraga Fernandez, Miguel Alberto ^{[15
]}

Bernal, Enrique ^{[16
]}

Antonia Sepulveda, Maria ^{[17
]}

Vivancos Gallego, Maria Jesus ^{[18
]}

Pedrero Tome, Roberto ^{[19
]}

Masia Canuto, Mar ^{[20
]}

Calderon Hernaiz, Ruth ^{[21
]}

Diez Romero, Cristina ^{[22
]}

Losa Garcia, Juan Emilio ^{[23
]}

Gutierrez Cuadra, Manuel ^{[24
]}

Llenas-Garcia, Jara ^{[25
]}

Cerezales Calvino, Ana ^{[26
]}

Sanchez Guirao, Antonio ^{[27
]}

Soler Gonzalez, Josefa ^{[28
]}

Estebanez, Miriam ^{[29
]}

de la Calle Riaguas, Beatriz ^{[30
]}

Angeles Garcinuno, Maria

Garcinuno Jimenez, Maria Angeles ^{[31
]}

Garcia Navarro, Maria del M. ^{[32
]}

Ramos Vicente, Noemi ^{[33
]}

Clavero Olmos, Marta ^{[34
]}

Egido Murciano, Miguel ^{[35
]}

Ferreira Pasos, Eva ^{[36
]}

Troya Garcia, Jesus ^{[19
]}

机构：

[1] Hosp Univ Burgos, Infect Dis, Burgos, Spain

[2] Hosp Univ La Paz, Infect Dis, Madrid, Spain

[3] Hosp Clin Univ Valencia, Infect Dis, Valencia, Spain

[4] Hosp Univ Guadalajara, Infect Dis, Guadalajara, Spain

[5] Hosp Univ Alvaro Cunqueiro, Infect Dis, Vigo, Spain

[6] Hosp Univ 12 Octubre, Infect Dis, Madrid, Spain

[7] Hosp Univ Princesa, Infect Dis, Madrid, Spain

[8] Hosp Univ Fdn Jimenez Diaz, Infect Dis, Madrid, Spain

[9] Hosp Clin San Carlos, Internal Med, Madrid, Spain

[10] Hosp Clin Univ Lozano Blesa, Infect Dis, Zaragoza, Spain

[11] Hosp Denia, Internal Med, Denia, Spain

[12] Hosp Univ Torrejon, Internal Med, Torrejon, Spain

[13] Hosp Univ Puerta Hierro, Infect Dis, Madrid, Spain

[14] Hosp Univ Miguel Servet, Infect Dis, Zaragoza, Spain

[15] Hosp Univ San Agustin, Internal Med, Aviles, Spain

[16] Hosp Gen Univ Reina Sofia, Infect Dis, Murcia, Spain

[17] Hosp Univ Toledo, Internal Med, Toledo, Spain

[18] Hosp Univ Ramon y Cajal, Infect Dis, Madrid, Spain

[19] Hosp Univ Infanta Leonor, Infect Dis, Madrid, Spain

[20] Hosp Gen Univ Elche, Infect Dis, Elche, Spain

[21] Hosp Univ Fuenlabrada, Internal Med, Fuenlabrada, Spain

[22] Hosp Univ Gregorio Maranon, Infect Dis, Madrid, Spain

[23] Hosp Univ Fdn Alcorcon, Infect Dis, Alcorcon, Spain

[24] Hosp Univ Marques de Valdecilla, Infect Dis, Santander, Spain

[25] Hosp Comarcal de la Vega Baja, Infect Dis, Alicante, Spain

[26] Hosp Univ Doctor Jose Molina Orosa, Infect Dis, Las Palmas Gran Canaria, Spain

[27] Hosp Gen Univ Morales Meseguer, Internal Med, Murcia, Spain

[28] Hosp Univ Cabuenes, Infect Dis, Gijon, Spain

[29] Hosp Cent Def Gomez Hulla, Infect Dis, Madrid, Spain

[30] Hosp Gen Nuestra Senora Prado, Clin Pharm, Talavera De La Reina, Spain

[31] Complejo Asistencial Avila, Internal Med, Avila, Spain

[32] Hosp Univ Vinalopo, Internal Med, Alicante, Spain

[33] Hosp Obispo Polanco, Internal Med, Teruel, Spain

[34] Hosp Univ Infanta Elena, Internal Med, Madrid, Spain

[35] Hosp Univ San Jorge, Internal Med, Huesca, Spain

[36] Complejo Asistencial Segovia, Internal Med, Segovia, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P056

引用

页码：66 / 68

页数：3

共 50 条

[1] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
Troya, Jesus
Morano, Luis
Ignacio Bernardino, Jose
Buzon Martin, Luis
Pedrero Tome, Roberto
Galindo Puerto, Maria Jose
Torralba, Miguel
Cabello Clotet, Noemi
Garcia Lopez, Maria
Lope, Silvia
de Zarraga Fernandez, Miguel Alberto
Cabello, Alfonso
Aguilera Garcia, Maria
Cecilio, Alvaro
Diaz de Santiago, Alberto
Garcinuno Jimenez, Maria Angeles
Bernal, Enrique
Lopez Caballero, Maria Teresa
Calderon Hernaiz, Ruth
Vivancos Gallego, Maria Jesus
Omiste Sanvicente, Teresa
Ferreira Pasos, Eva
Losa Garcia, Juan Emilio
Soler Gonzalez, Josefa Francisca
Antonia Sepulveda, Maria
Garcia Navarro, Maria del Mar
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
[2] Real-world utilization of cabotegravir plus rilpivirine in Southern Spain: data from the CARIPLA study
Palacios, Rosario
Gomez-Ayerbe, Cristina
Mayorga, Marisa
Espinosa, Nuria
Hidalgo, Alicia
Tellez, Francisco
Lozano, Ana Belen
Loring, Monica
Santos, Jesus
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 94 - 94
[3] Two year outcomes of dolutegravir/rilpivirine in virologically suppressed HIV-infected PLHIV: real-world data from the German JUNGLE cohort
Ummard-Berger, K.
Wyen, C.
Schabaz, F.
Hillenbrand, H.
Beer, D.
Schneeweiss, S.
Weinberg, G.
Postel, N.
Westermayer, B.
Dymek, K. M.
Scherzer, J.
HIV MEDICINE, 2021, 22 : 76 - 76
[4] Real-world oncological outcomes of a nationwide, prospective bladder cancer cohort
Van Hoogstraten, L.
Kiemeney, L. A. L. M.
Meijer, R. P.
Witjes, J. A.
Aben, K. K. H.
EUROPEAN UROLOGY, 2024, 85 : S1354 - S1354
[5] Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma
Rantala, Elina S.
Kivela, Tero T.
Hernberg, Micaela M.
MELANOMA RESEARCH, 2021, 31 (03) : 224 - 231
[6] Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study
Shimoyama, Rai
Imamura, Yoshinori
Uryu, Kiyoaki
Mase, Takahiro
Fujimura, Yoshiaki
Hayashi, Maki
Ohtaki, Megu
Ohtani, Keiko
Shinozaki, Nobuaki
Minami, Hironobu
HEALTHCARE, 2022, 10 (11)
[7] Effectiveness of cladribine in real-world setting: a Slovak multicentre cohort study
Szilasiova, Jarmila
Bila, Anna
Cimprichova, Andrea
Dziakova, Jana
Filippi, Pavol
Jankovicova, Zuzana
Karlik, Martin
Kornajova, Jana
Laurincova, Silvia
Megova, Andrea
Rohalova, Jana
Kovacova, Slavomira
Kantorova, Ema
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 383 - 383
[8] Process evaluation and early outcomes of real-world implementation of a pharmacist-driven cabotegravir/rilpivirine long-acting injectable initiative
Derrick, Caroline B.
Magee, Matthew
Tsai, Y. Vivian
Pizzuti, Morgan E.
Parker, Sarah
Lucas, Omar
Taylor, Kara
Albright, Raeghan
Langehans, Briley
Schreiber, Danny
Guest, Georgia
Ahuja, Divya
Weissman, Sharon
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
[9] Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study
Bosco-Levy, Pauline
Briot, Karine
Mehsen-Cetre, Nadia
O'Kelly, James
Desamericq, Gaelle
Abouelfath, Abdelilah
Lassalle, Regis
Grelaud, Angela
Grolleau, Adeline
Blin, Patrick
Droz-Perroteau, Cecile
JBMR PLUS, 2023, 7 (09)
[10] Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study
Yu, Hee Tae
Yang, Pil-Sung
Kim, Tae-Hoon
Jang, Eunsun
Kim, Daehoon
Uhm, Jae-Sun
Kim, Jong-Youn
Pak, Hui-Nam
Lee, Moon-Hyoung
Lip, Gregory Y. H.
Joung, Boyoung
STROKE, 2018, 49 (10) : 2421 - 2429

← 1 2 3 4 5 →